Related Experiment Video
Updated: Jun 22, 2026

Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
Esophageal Cancer-Related Gene-4 Contributes to Lipopolysaccharide-Induced Ion Channel Dysfunction in hiPSC-Derived
Qiang Xu1,2, Xiangjie Zhang3, Maolin Hao3
1School of Basic Medical Science, Southwest Medical University, Luzhou, People's Republic of China.
Background And Purpose:
Esophageal cancer-related gene-4 (ECRG4) participate in inflammation process and can interact with the innate immunity complex TLR4-MD2-CD14 on human granulocytes. In addition, ECRG4 participate in modulation of ion channel function and electrical activity of cardiomyocytes. However, the exact mechanism is unknown. This study aimed to test our hypothesis that ECRG4 contributes to inflammation-induced ion channel dysfunctions in cardiomyocytes.
Methods:
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) generated from three donors were treated with lipopolysaccharide (LPS) to establish an endotoxin-induced inflammatory model. Immunostaining, real-time PCR, and patch-clamp techniques were used for the study.
Results:
ECRG4 was detected in hiPSC-CMs at different differentiation time. LPS treatment increased ECRG4 expression in hiPSC-CMs. Knockdown of ECRG4 decreased the expression level of Toll-Like-Receptor 4 (TLR4, a LPS receptor) and its associated genes and inflammatory cytokines. Furthermore, ECRG4 knockdown shortened the action potential duration (APD) and intercepted LPS-induced APD prolongation by enhancing ISK (small conductance calcium-activated K channel current) and attenuating INCX (Na/Ca exchanger current). Overexpression of ECRG4 mimicked LPS effects on ISK and INCX, which could be prevented by NFκB signaling blockers.
Conclusion:
This study demonstrated that LPS effects on cardiac ion channel function were mediated by the upregulation of ECRG4, which affects NFκB signaling. Our findings support the roles of ECRG4 in inflammatory responses and the ion channel dysfunctions induced by LPS challenge.
Insights
Esophageal cancer-related gene-4 (ECRG4) exacerbates inflammation-induced cardiac ion channel dysfunction by upregulating Toll-Like-Receptor 4 and affecting NFκB signaling. ECRG4 plays a key role in inflammatory responses in cardiomyocytes.
Area of Science:
- Cardiology
- Molecular Biology
- Immunology
Background:
- Esophageal cancer-related gene-4 (ECRG4) is implicated in inflammation and modulates ion channel function in cardiomyocytes.
- The precise mechanisms by which ECRG4 influences cardiac electrical activity during inflammation remain unclear.
Purpose of the Study:
- To investigate the role of ECRG4 in inflammation-induced ion channel dysfunction in cardiomyocytes.
- To elucidate the molecular mechanisms linking ECRG4, inflammation, and cardiac electrophysiology.
Main Methods:
- Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were exposed to lipopolysaccharide (LPS) to model endotoxin-induced inflammation.
- Techniques included immunostaining, real-time PCR, and patch-clamp electrophysiology.
- ECRG4 expression was manipulated via knockdown and overexpression.
Main Results:
- LPS treatment increased ECRG4 expression in hiPSC-CMs.
- ECRG4 knockdown reduced Toll-Like-Receptor 4 (TLR4) expression, inflammatory markers, and normalized action potential duration (APD) by modulating ISK and INCX.
- ECRG4 overexpression mimicked LPS effects on ion currents, which were sensitive to NFκB signaling inhibition.
Conclusions:
- LPS-induced cardiac ion channel dysfunction is mediated by ECRG4 upregulation and subsequent effects on NFκB signaling.
- ECRG4 is a critical mediator of inflammatory responses and ion channel dysregulation in cardiomyocytes during endotoxemia.
More Related Videos
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Related Concept Videos
Hedgehog Signaling Pathway
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Esophageal Achalasia